Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Dongxu Kang"'
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Second-line treatment for metastatic or locally advanced urothelial cancer (UC) is limited. Immunotherapy is approved as a second-line treatment for metastatic UC. Its use as a first-line agent is limited to patients who are ineligible for cisplatin-
Externí odkaz:
https://doaj.org/article/e21302c6b7a443bb9b6a8b30bf2cb16b
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundIrinotecan-loaded drug-eluting beads transarterial chemoembolization (DEBIRI-TACE) is a safe and effective therapeutic option for unresectable colorectal liver metastases (CRLM). The evaluation of treatment response after DEBIRI-TACE is ver
Externí odkaz:
https://doaj.org/article/4e6a98cd8b6241c3807185691da68ac4
Autor:
Zhezhu Han, Dongxu Kang, Yeonsoo Joo, Jihyun Lee, Geun-Hyeok Oh, Soojin Choi, Suwan Ko, Suyeon Je, Hye Jin Choi, Jae J. Song
Publikováno v:
Experimental and Molecular Medicine, Vol 50, Iss 12, Pp 1-19 (2018)
Cancer: Tipping the signaling balance Reducing the levels of the multifunctional protein transforming growth factor (TGF)-β in cancer cells prevents tumor growth in mice. Previous studies have shown that high levels of TGF-β in cancerous tissue are
Externí odkaz:
https://doaj.org/article/88e935c017ed4a64845a571c7fa1db78
Publikováno v:
Indian Journal of Pharmaceutical Sciences. 84
Publikováno v:
Semiconductor Science and Technology. 38:015017
The emergence of vertical GaN devices solves the problem of insufficient voltage withstand capacity of horizontal GaN devices. However, the current output capability of vertical GaN devices is not comparable to that of lateral GaN devices. So we prop
Autor:
Hye Jin Choi, Soo Jin Choi, Dongxu Kang, Geun-Hyeok Oh, Zhezhu Han, Suwan Ko, Suyeon Je, Jihyun Lee, Jae J. Song, Yeonsoo Joo
Publikováno v:
Experimental and Molecular Medicine, Vol 50, Iss 12, Pp 1-19 (2018)
Experimental & Molecular Medicine
Experimental & Molecular Medicine
Transforming growth factor (TGF)-β signaling is increasingly recognized as a key driver in cancer. In progressive cancer tissues, TGF-β promotes tumor formation, and its increased expression often correlates with cancer malignancy. In this study, w
Publikováno v:
Oncotarget
// So Young Kim 1, * , Dongxu Kang 1, 2, * , Hye Jin Choi 3 , Yeonsoo Joo 1, 4 , Joo-Hang Kim 5 , Jae J. Song 1, 4 1 Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea 2 Department of Oncology, Affiliated Hospital of Y
Autor:
Kexin Yu, Xianchun Zhou, Zhezhu Han, Xianglan Quan, Dongxu Kang, Ying Li, Yongmin Jin, Wenbiao Jin, Shengji Li, Tiefeng Jin, Songnan Zhang
Publikováno v:
Investigación Clínica; 2020, Vol. 61 Issue 3, p1605-1613, 9p
Autor:
J. K. Park, Dongxu Kang, Sun Min Lim, Hyo-Yeon Kim, H. Haack, Hyo Sup Shim, Susan S. Jewell, Ross A. Soo, Joo Hang Kim, Sai-Hong Ignatius Ou, Byoung Chul Cho, Sohyun Hwang, Eunah Shin, Mi Kyung Bae, Jiuzhou Wang, Hye Ryun Kim
Publikováno v:
Annals of Oncology. 24:2364-2370
Background To determine the frequency and predictive impact of ROS1 rearrangements on treatment outcomes in never-smoking patients with lung adenocarcinoma. Patients and methods We concurrently analyzed ROS1 and ALK rearrangements and mutations in th
Publikováno v:
Cellular Signalling. 25:1288-1300
Curcumin as an anticancer agent was investigated in regards to its ability to regulate the switching of cancer cells from survival to necrotic cell death. At higher concentrations, curcumin induced ROS production leading to JNK and p38 phosphorylatio